Related Experiment Video
Updated: Jul 24, 2026
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
NIH symposium summary: organ preservation therapies for squamous cancers of the head and neck
B A Conley1, R Cumberlin, A Sandberg
1Diagnostics Research Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20852, USA. conleyb@mail.nih.gov
Abstract:
This symposium, sponsored by the NIH Office of Rare Diseases, the National Cancer Institute, the National Institute of Deafness and Other Communication Disorders, and the National Institute of Dental and Craniofacial Diseases, reviewed the current status of organ preservation therapies for head and neck cancers, as well as promising newer approaches for therapy and for toxicity amelioration.
Insights
This symposium reviewed organ preservation therapies for head and neck cancers. Promising new treatments and toxicity reduction strategies were discussed for improved patient outcomes.
Area of Science:
- Oncology
- Head and Neck Surgery
- Medical Research
Background:
- The symposium focused on organ preservation therapies for head and neck cancers.
- It addressed the current status and future directions in managing these malignancies.
- Key funding bodies included the NIH Office of Rare Diseases, National Cancer Institute, and others.
Framework:
- Review of existing organ preservation techniques.
- Exploration of novel therapeutic strategies.
- Discussion on mitigating treatment-related toxicities.
Implementation:
- The symposium served as a platform for experts to share insights.
- It facilitated a comprehensive review of current and emerging treatments.
- Focus on multidisciplinary approaches to head and neck cancer care.
Implications:
- Potential for improved organ preservation in head and neck cancer patients.
- Advancement of novel therapies with reduced side effects.
- Enhanced understanding of rare diseases impacting head and neck region.
